tiprankstipranks
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1

KalVista Pharmaceuticals (4XC1) Balance Sheet

0 Followers

KalVista Pharmaceuticals Balance Sheet

KalVista Pharmaceuticals's total assets for Q3 2024 were $113.97M, a decrease of -17.86% from the previous quarter. DE:4XC1 total liabilities were $25.39M for the fiscal quarter, a 4.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Apr 23Apr 22Apr 21Apr 20Apr 19
Total Assets
$ 183.23M$ 203.88M$ 272.01M$ 92.53M$ 118.13M
Total Liabilities
$ 22.18M$ 18.79M$ 14.82M$ 8.78M$ 21.39M
Total Equity Gross Minority
$ 161.01M$ 185.09M$ 257.19M$ 83.75M$ 96.74M
Total Capitalization
$ 161.01M$ 185.09M$ 257.19M$ 83.75M$ 96.74M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 5.91M$ 1.65M$ 0.00
Currency in USD

KalVista Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis